Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 30, 2022European Respiratory JournalOpen Access

Prognostic factors in nonsmall cell lung cancer: insights from the German CRISP registry

View Full Paper
Ask AI
Bookmark
Share

Authors

MMMartin MetzenmacherFGFrank GriesingerHHHorst-Dieter Hummel

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Metzenmacher et al. (2022) studied this question.

synapsesocial.com/papers/6a73667e64cdd4095c2c2a38https://doi.org/10.1183/13993003.01336-2022
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC): updated results, including overall survival, from PROFILE 10012019 · 593 citations
  2. 2Risk factors and management of oligometastatic non-small cell lung cancer2016 · 18 citations
  3. 3Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update2020 · 457 citations
  4. 4Updating and Validating the Charlson Comorbidity Index and Score for Risk Adjustment in Hospital Discharge Abstracts Using Data From 6 Countries2011 · 6,052 citations
  5. 5Five Year Survival Update From KEYNOTE-010: Pembrolizumab Versus Docetaxel for Previously Treated, Programmed Death-Ligand 1–Positive Advanced NSCLC2021 · 322 citations